Abstract:Background To investigate the therapeutic potential of combined therapy with polyethylene glycol‐20k (PEG‐20k) and MCC950 on post‐resuscitation myocardial function in a rat model of cardiac arrest. Methods and Results Thirty rats were randomized into 5 groups: Sham, Control, PEG‐20k, MCC950, PEG‐20k+ MCC950. Except for sham, animals were subjected to 6 minutes of ventricular fibrillation followed by 8 minutes cardiopulmonary resuscitation. Two milliliters PEG‐20k was administered by intravenous injection coincident with the start of cardiopulmonary resuscitation; MCC950 (10 mg/kg), a highly selective NLRP3 inflammasome inhibitor, was delivered immediately after restoration of spontaneous circulation. Myocardial function, sublingual microcirculation, mitochondrial function, plasma cardiac troponin I, and interleukin‐1β, expression of proteins in SIRT1 (sirtuin 1)/PGC‐1α (peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha) and NLRP3 (the NOD‐like receptor family protein 3) inflammasome pathways were evaluated. Following cardiopulmonary resuscitation, myocardial function was compromised with a significantly decreased cardiac output, ejection fraction, and increased myocardial performance index, cardiac troponin I. Sublingual microcirculation was disturbed with impaired perfused vessel density and microvascular flow index. Cardiac arrest reduced mitochondrial routine respiration, Complex I‐linked respiration, respiratory control rates and oxidative phosphorylation coupling efficiency. PEG‐20k or MCC950 alone restored mitochondrial respiratory function, restituted sublingual microcirculation, and preserved myocardial function, whereas a combination of PEG‐20k and MCC950 further improved these aspects. PEG‐20k restored the expression of SIRT1 and PGC‐1α, and blunted activation of NLRP3 inflammasomes. MCC950 suppressed expression of cleaved‐caspase‐1/pro‐caspase‐1, ASC (apoptosis‐associated speck‐like protein), GSDMD [gasdermin d], and interleukin‐1β. Conclusions Combined therapy with PEG‐20k and MCC950 is superior to either therapy alone for preserving post‐resuscitated myocardial function, restituting sublingual microcirculation at restoration of spontaneous circulation at 6 hours. The responsible mechanisms involve upregulated expression of SIRT1/PGC1‐α in tandem with inhibition of NLRP3 inflammasomes.

Abstract 223: PBEF/Nampt Protects Against Mouse Sudden Cardiac Arrest Injury

Neuronal Protective Role of PBEF in a Mouse Model of Cerebral Ischemia

Abstract 12474: Nicotinamide Restores Tissue Nad + and Improves Outcomes in a Murine Model of Cardiac Arrest

Abstract 13483: Peptide Inhibition of PTEN Improves Metabolic Recovery and Outcomes in a Murine Cardiac Arrest Model

Abstract 323: A Peptide Inhibitor of PTEN Improves Mouse Survival after Cardiac Arrest

A novel pharmacological strategy by PTEN inhibition for improving metabolic resuscitation and survival after mouse cardiac arrest.

Abstract 18940: Pre-B-Cell Colony Enhancing Factor Blood Levels Correlate with Intravenous Catecholamine Use and Post-Resuscitation Death after Out-of-Hospital Cardiac Arrest

Abstract 17773: Peptide Inhibition of PTEN Increases Mouse Survival after Sudden Cardiac Arrest

Effects of the Selective NLRP3-Inflammasome Inhibitor MCC950 on Post-Resuscitationyocardial and Cerebral Function in a Rat Model of Cardiopulmonary Resuscitation

Examination of Physiological Function and Biochemical Disorders in a Rat Model of Prolonged Asphyxia-Induced Cardiac Arrest Followed by Cardio Pulmonary Bypass Resuscitation.

Abstract 332: Novel Peptide Administered During CPR Improves Long-Term Survival after Prolonged Cardiac Arrest

Abstract 179: Effects of Necrosulfonamide on Post-Resuscitation Survival and Neurological Function in a Rat Model of Cardiac Arrest

Abstract 276: TAT-PTEN9c Targets Heart Directly to Improve Survival from Cardiac Arrest

Abstract 19769: Cardiac Injury and Stunning after Ischemia is Related to Loss of PBEF/Nampt Function and is Rescued by PTEN Inhibition

Abstract 253: Increased Blood Brain Barrier Permeability after Successful Resuscitation in a Rat Model of Cardiac Arrest

Abstract 101: PHLPP Inhibitory Peptide Administered During CPR Improves Survival after Prolonged Cardiac Arrest

Improvement in Outcomes and Prevention of Multiple Organ Dysfunction Syndrome After Cardiac Arrest and Successful Cardiopulmonary Resuscitation by Systemic Administration of Bumetanide in Male Mice

Combined Therapy with Polyethylene Glycol‐20k and MCC950 Preserves Post‐Resuscitated Myocardial Function in a Rat Model of Cardiac Arrest and Cardiopulmonary Resuscitation

Early Effects of Prolonged Cardiac Arrest and Ischemic Postconditioning during Cardiopulmonary Resuscitation on Cardiac and Brain Mitochondrial Function in Pigs

Abstract 359: the Effect of BDNF on the Neuroprotection of Win55,212-2 Pharmacological Hypothermia after CPR in a Rat Cardiac Arrest Model

Abstract 168: Circulating Blood Neutrophils Are the Main Source of Plasma Nampt after Cardiac Arrest